MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Genprex, Inc. Common Stock

GNPX

#4509
Genprex, Inc. Common Stock
2.0100 USD
+2.55%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.0100
2.0100
Year Range
1.7500
2.6093
Daily Change
+2.55%
Monthly Change
+7.49%
6 month change
+7.49%
Year Change
+7.49%
Previous Close
1.9600
Open
2.0100
Bid
2.0100
Ask
2.0130
Low
2.0100
High
2.0100
Volume
16
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. GNPX
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.5286 M
  • Employee 13
  • Founded 2009
  • CEO N/A
  • Website www.genprex.com
  • Headquarter Texas, United States
  • FIGI BBG00F7T0157
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
1.53 M Market capitalization

News

Investing Investing
GNPX
2026.02.23
Genprex stock jumps on Japan, Europe patent approvals
Investing Investing
GNPX
2026.02.23
Genprex receives Japanese and European patents for cancer therapy
Investing Investing
GNPX
2026.02.10
Genprex receives patent approval in Australia for cancer therapy
Investing Investing
GNPX
2026.01.06
Genprex reports positive data for diabetes gene therapy in animal studies
Investing Investing
GNPX
2025.12.23
Genprex reports potential compliance with Nasdaq equity listing rule
Investing Investing
GNPX
2025.11.24
Genprex reports phase 1 data for lung cancer gene therapy
Investing Investing
GNPX
2025.11.18
Genprex receives US patent for cancer therapy combination
Investing Investing
GNPX
2025.11.04
Genprex to receive European patent for cancer gene therapy combination
Investing Investing
GNPX
2025.10.28
Genprex stock tumbles after announcing $3.4 million registered offering
Investing Investing
GNPX
2025.10.28
Genprex announces $3.4 million registered direct offering
Investing Investing
GNPX
2025.10.28
Genprex stock soars after positive preclinical lung cancer treatment data
Investing Investing
GNPX
2025.10.28
Genprex reports positive preclinical data for lung cancer gene therapy

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
MQL5 Channels
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Economic Calendar
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd